Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis

被引:0
|
作者
Mitsani, D. [1 ]
Nguyen, H. [1 ]
Shields, R. [1 ]
Toyoda, Y. [1 ]
Bhama, J. [1 ]
Kwak, E. [1 ]
Silveira, F. [1 ]
Pilewski, J. [1 ]
Crespo, M. [1 ]
Clancy, C. [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源
关键词
D O I
10.1016/j.healun.2011.01.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
105
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [31] Voriconazole therapeutic drug monitoring
    Michael, C.
    Teichert, J.
    Niederwieser, D.
    Preiss, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 367 - 368
  • [32] Isavuconazole (ISA) versus Voriconazole (VOR) Prophylaxis (px) in Lung Transplant Recipients (LTR)
    Samanta, P.
    Clancy, C. J.
    Marini, R. V.
    Rivosecchi, R.
    McCreary, E. K.
    Shields, R. K.
    Falcione, B. A.
    Viehman, A.
    Sacha, L.
    Kwak, E. J.
    Silveira, F. P.
    Clarke, L.
    Nguyen, M. H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 608 - 608
  • [33] Therapeutic drug monitoring of voriconazole
    Bruggemann, Roger J. M.
    Donnelly, J. Peter
    Aarnoutse, Rob E.
    Warris, Adilia
    Blijlevens, Nicole M. A.
    Mouton, Johan W.
    Verweij, Paul E.
    Burger, David M.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 403 - 411
  • [34] Voriconazole therapeutic drug monitoring
    Smith, J
    Safdar, N
    Knasinski, V
    Simmons, W
    Bhavnani, SM
    Ambrose, PG
    Andes, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) : 1570 - 1572
  • [35] Voriconazole therapeutic drug monitoring
    Aouinti, I.
    Gaies, E.
    Trabelsi, S.
    Jebabli, N.
    Salouage, I.
    Charfi, R.
    Lakhal, M.
    Klouz, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 67 - 67
  • [36] Voriconazole Therapeutic Drug Monitoring
    Hoy, Zachary
    Ashley, Elizabeth S. Dodds
    Weinberg, Geoffrey A.
    Krysan, Damian J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2014, 3 (03) : 270 - 271
  • [37] Therapeutic drug monitoring of sirolimus in renal transplant recipients
    Chenailler, C.
    Snanoudj, P.
    Quteineh, L.
    Taburet, A. M.
    Furlan, V.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 531 - 532
  • [38] Prophylaxis in Lung Transplant Recipients
    Malo, Joshua
    Natt, Bhupinder
    Chaudhary, Sachin
    Knox, Kenneth S.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (02) : 368 - 369
  • [39] Preemptive treatment with voriconazole in lung transplant recipients
    Neoh, C. F.
    Snell, G. I.
    Levvey, B.
    Kotsimbos, T.
    Morrissey, C. O.
    Slavin, M. A.
    Stewart, K.
    Kong, D. C. M.
    TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (04) : 344 - 353
  • [40] Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children
    Allegra, Sarah
    Fatiguso, Giovanna
    De Francia, Silvia
    Favata, Fabio
    Pirro, Elisa
    Carcieri, Chiara
    De Nicolo, Amedeo
    Cusato, Jessica
    Di Perri, Giovanni
    D'Avolio, Antonio
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (01) : 197 - 203